Virtual 2021 BioHealth Capital Region Forum

Top 3 by 2023

September 13-14, 2021 Two Half-Days

 

20% of the top influencers worldwide in vaccine development

 

World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine

1
1

MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

BioHealth Capital Region Partners

U.S. Pharmacopeia launches suite of resources to detect substandard and falsified COVID-19 treatments

May 17, 2021

New methods were created in collaboration with public health organizations, pharmacopeias, regulators, and manufacturers to help ensure quality and improve public trust Rockville, MD, May 17, 2021 – The U.S. Pharmacopeia (USP) announced…

QIAGEN Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies

May 12, 2021

U.S. authorization gives healthcare professionals access to portable rapid testing device that can monitor immune status in relation to COVID-19 Test based on QIAGEN partner Ellume’s proprietary eHub technology and…

Emmes Acquires UK-Based Orphan Reach

May 12, 2021

ROCKVILLE, Md., May 12, 2021 /PRNewswire/ — Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of…

Adaptive Phage Therapeutics Announces $40.75 Million Series B Financing

May 11, 2021

GAITHERSBURG, MD., May 11, 2021 – Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the company has closed a $40.75…

Global Biotech Company, Ellume, to Open Manufacturing Facility in Frederick

May 10, 2021

BALTIMORE, MARYLAND (May 10, 2021) – Governor Larry Hogan today announced that Ellume, an Australia-based digital diagnostics company, will establish its first U.S. manufacturing operation in Frederick County and create more…

Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

May 10, 2021

GAITHERSBURG, Md., May 10, 2021 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data from a preclinical study of the company’s combination quadrivalent seasonal…